Search

Your search keyword '"Abu-Rustum, Nadeem R."' showing total 36 results

Search Constraints

Start Over You searched for: Author "Abu-Rustum, Nadeem R." Remove constraint Author: "Abu-Rustum, Nadeem R." Publication Year Range This year Remove constraint Publication Year Range: This year
36 results on '"Abu-Rustum, Nadeem R."'

Search Results

6. Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake

7. Bridging Communication Gaps Between Radiologists, Referring Physicians, and Patients Through Standardized Structured Cancer Imaging Reporting: The Experience with Female Pelvic MRI Assessment Using O-RADS and a Simulated Cohort Patient Group

10. Molecular profiling of primary endometroid endometrial cancer and matched lung metastases: CTNNB1 mutation as a potential driver

11. Novel Androgen Receptor Splice Variant 7 in Gynecologic Tumors

12. Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer

13. ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability‐high (MSI‐H) molecular subtype.

16. Uterine washings as a novel method for early detection of ovarian cancer: Trials and tribulations

17. ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancer.

18. A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary study.

21. Trachelectomy and Cerclage Placement as Fertility Sparing Surgery for Cervical Cancer – a Worldwide Survey

25. Five-year quality-of-life assessment by urinary diversion type after pelvic Exenterations.

26. 2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or both.

27. Oncologic outcomes based on lymphovascular space invasion in node-negative FIGO 2009 stage I endometrioid endometrial adenocarcinoma: a multicenter retrospective cohort study.

28. Lymph node metastases in endometrial carcinoma: A modern assessment in the era of sentinel lymph node mapping and molecular subtyping.

29. Concurrent POLE hotspot mutations and mismatch repair deficiency/microsatellite instability in endometrial cancer: A challenge in molecular classification.

30. Impact of adjuvant therapy on oncologic outcomes in uterine-confined clear cell carcinoma of the endometrium.

31. Assessing minimally invasive simple hysterectomy in low risk cervical cancer: set up for the LASH trial.

32. Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE.

33. Tracking clonal evolution of drug resistance in ovarian cancer patients by exploiting structural variants in cfDNA.

34. Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancer.

35. Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.

36. Pathogenic germline variants in patients with endometrial cancer of diverse ancestry.

Catalog

Books, media, physical & digital resources